This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients.
PBMs, insurers, pharmacompanies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Google is also giving health records another whirl.
In 2023, there were significant advancements and notable trends in the lifesciences. Xtalks compiled a list of its top lifescience news and trends of 2023, which provided readers with the latest developments, information and expert insights across lifescience industries, including pharma, biotech and medical device.
Meanwhile, field teams’ promotional content is still reflective of the pre-COVID paradigm, and Noel says companies need to rethink what content messages will be beneficial for HCPs. Reps should not just be pushing product messages – they should be asking doctors what they need right now and how they can help.”.
Since the onset of the Covid-19 pandemic, lifesciencecompanies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, lifesciencecompanies have a relatively good knowledge of what their audiences want and need from them.
The past two years have shone a spotlight on the UK lifesciences industry. Pharmacompanies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. An industry that will forever play a greater role in our everyday lives. About the author.
Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in lifesciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the lifesciences industry creates content.
We just have to use the doctors, the pharmaceutical representatives, the technology representatives. According to Nandwana, the way to streamline communication is by creating a personalized experience for physicians, which requires a change from pharma’s traditional one-directional push of communications out to doctors. “We
Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from lifesciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a lifesciences future very much immersed in speciality medicine?
Because digital permeates every aspect of the industry, and people are often talking about digital and maybe talking about very different things, I think about the journey of healthcare and lifesciencecompanies in three stages,” he explained. The first stage of digital transformation was really all about communications.
The oceans of health data out there can be overwhelming for pharmacompanies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. .
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharmacompanies’ customer communication methods require reimagining as technology progresses. About the author.
As a patient goes through their prescribing journey, they meet many different people, and one’s meeting with their doctor may be brief compared to the time spent with others. Lapolla states one personnel member told him they are excited pharma reps are coming back because they provide valuable information and educational materials.
This included segregated wards at Johns Hopkins containing Black patients with cervical cancer whom white doctors would collect samples from without their knowledge or consent. However, the agreement did not include a share of any profits that researchers or pharmacompanies may make from use of the cells.
Pharmacompanies are still spending billions of dollars a year on TV advertising in the US – but many of the industry’s media strategies are based on assumptions from traditional, linear TV, despite TV consumption becoming increasingly fragmented across platforms and devices. Pharmacompanies need to change everything,” says Chase.
The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. The FDA also issued a Rare Pediatric Disease Priority Review Voucher (PRV) to Ipsen that can be used for subsequent drug applications that would not qualify for a priority review.
“Let’s say a doctor changes his professional title on a hospital’s web page. We think customer data should cover the complete ecosystem, with flexible usage, real-time updates and insights embedded in CRM, to help pharmacompanies be more successful in their engagement with their stakeholders.” About Veeva Systems.
The 2021 WIRED Health conference took a broad view of the current pandemic situation, with speakers ranging from geneticists to intensive care doctors. BioNTech seeks “new kind of pharmacompany”. But in general, governments should be praised, not stigmatised for their transparency.”. “We
“We can couple that with claims data and directly look at healthcare resource utilisation and see which doctors patients are visiting and if they are going to the emergency room or urgent care because of pain,” Sackman states. “This is just a remarkable shift in the culture of how clinical trials are run. About the author.
“That is something very unique because there are lots of patient apps out there, but they do not communicate with the doctor. Though the above offerings will benefit African patients and the system overall, garnering partners helps companies such as Philips improve health networks in ways it couldn’t otherwise do.
While “it creates opportunities for organizations to truly look at [the patient] experience from a new lens,” she said, comms teams may find it challenging to change how they typically reach and respond to their audiences, especially as GLP-1 influencers increasingly overtake doctors as the most authoritative voices for interested patients.
Such partnerships are mutually beneficial for all involved parties as pharmacompanies have a wealth of data, insight, and connections at their disposal, resources that can play a central role in enabling early diagnosis for the NHS and patients. Our ambition is to eliminate cancer as a cause of death.
Before posting the commercial, she also shared a video on the social media platform in which she encouraged people with migraine to talk to their doctors about the medication. “I The same criticism erupted on Gaga’s recent Instagram posts about her new ad with Pfizer, with some people lambasting her for getting paid by the company.
In the beginning, I always thought I wanted to be a doctor, but then I felt it was very depressing, particularly at that time and in that particular field. So, I [decided] to go into research rather than be a doctor and see patients [such as that] young, beautiful life that you could do nothing about it.”.
Fifteen percent of those surveyed said they trust pharmacompanies more than before. However, on the flip side, only 16% believe pharmacompanies “market their products in a trustworthy manner,” and just 17% would allow pharmacompanies to work with their doctors to manage a chronic illness.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content